Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Stephane Bancel

mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%

Moderna CEO Stephane Bancel said the findings open a new chapter in cancer treatment

The Independent UK · Oct 22

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

WASHINGTON (UNITED STATES) - US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."

Bangkok Post · Aug 19

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

The late-stage clinical trial was described as a "landmark moment."

International Business Times · Aug 19

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna takes swipe at Trump as it opens new UK factory: ‘A country that still believes in vaccination’

New opening comes amid a rise in anti-vax attitudes within the Trump administration

The Independent UK · Sep 25, 2025

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga · Jul 31, 2025

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

MarketBeat · Mar 11, 2025

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

International Business Times UK · Jan 14, 2025

Read news from The Economist, FT, and more,
with one subscription

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Latin Times · Dec 15, 2023

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times · Dec 14, 2023

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune · Apr 26, 2023

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Independent UK · Mar 22, 2023

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service · Dec 31, 2022

Moderna jab ‘to protect through the winter’ after positive new results

The main Covid-19 booster offers good protection for at least three months.

The Independent UK · Oct 19, 2022

Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More…

Full details of next Covid booster rollout -and Omicron jab will be used

The Government has confirmed who will get another Covid injection and says new vaccine will be used

The Independent UK · Aug 15, 2022

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

Daily Record · Aug 15, 2022

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

Manchester Evening News · Aug 15, 2022

New Moderna vaccine to target two Covid strains in one dose

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

Get all your
news in one place.

100's of premium titles.
One news app.

The National (Scotland) · Aug 15, 2022

'Next generation' Covid jab approved in UK for use in adults

A new coronavirus booster jab has been approved for use in adults.

Daily Mirror · Aug 15, 2022

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

Evening Standard · Aug 15, 2022

First Covid vaccine that targets two variants approved in UK

The ‘next generation’ Moderna jab may only need to be administered once a year

Wales Online · Aug 15, 2022

Once-a-year Covid jab approved for use in adults in UK

The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron

The Independent UK · Aug 15, 2022

‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults

The jab is the first to target two strains of Covid-19.

Benzinga · Jun 22, 2022

Moderna To establish New Vaccine Facility In Britain

Moderna Inc (NASDAQ:MRNA) announced an agreement with the United Kingdom government to establish an mRNA Innovation and Technology Center in the U.K. Additionally, Moderna plans to expand its presence in the U.K. through investments in R&D activities. Moderna is collaborating with the National Institute for Health Research on a Phase 3 study…

Benzinga · May 25, 2022

Time 100 Most Influential List Includes 10 Connected To Public Companies Such As Tim Cook, Andy Jassy And Joe Rogan

The annual Time 100 Most Influential People list for 2022 contains names such as U.S. President Joe Biden, Ukrainian President Volodymyr Zelenskyy and Chinese President Xi Jinping. The list also has several CEOs and names connected to public companies.

1 2

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

The Latest Breaking News from Stephane Bancel

mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

Moderna takes swipe at Trump as it opens new UK factory: ‘A country that still believes in vaccination’

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

Senators press Moderna CEO on COVID-19 vaccine price hike

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

Moderna jab ‘to protect through the winter’ after positive new results

Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More…

Full details of next Covid booster rollout -and Omicron jab will be used

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

New Moderna vaccine to target two Covid strains in one dose

'Next generation' Covid jab approved in UK for use in adults

UK becomes first country to approve new Covid jab specifically targeting Omicron

First Covid vaccine that targets two variants approved in UK

Once-a-year Covid jab approved for use in adults in UK

‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults

Moderna To establish New Vaccine Facility In Britain

Time 100 Most Influential List Includes 10 Connected To Public Companies Such As Tim Cook, Andy Jassy And Joe Rogan

Coverage From